From classic to spontaneous and humanized models of multiple sclerosis: impact on understanding pathogenesis and drug development
- PMID: 25175979
- DOI: 10.1016/j.jaut.2014.06.004
From classic to spontaneous and humanized models of multiple sclerosis: impact on understanding pathogenesis and drug development
Abstract
Multiple sclerosis (MS), a demyelinating disease of the central nervous system (CNS), presents as a complex disease with variable clinical and pathological manifestations, involving different pathogenic pathways. Animal models, particularly experimental autoimmune encephalomyelitis (EAE), have been key to deciphering the pathophysiology of MS, although no single model can recapitulate the complexity and diversity of MS, or can, to date, integrate the diverse pathogenic pathways. Since the first EAE model was introduced decades ago, multiple classic (induced), spontaneous, and humanized EAE models have been developed, each recapitulating particular aspects of MS pathogenesis. The advances in technologies of genetic ablation and transgenesis in mice of C57BL/6J background and the development of myelin-oligodendrocyte glycoprotein (MOG)-induced EAE in C57BL/6J mice yielded several spontaneous and humanized EAE models, and resulted in a plethora of EAE models in which the role of specific genes or cell populations could be precisely interrogated, towards modeling specific pathways of MS pathogenesis/regulation in MS. Collectively, the numerous studies on the different EAE models contributed immensely to our basic understanding of cellular and molecular pathways in MS pathogenesis as well as to the development of therapeutic agents: several drugs available today as disease modifying treatments were developed from direct studies on EAE models, and many others were tested or validated in EAE. In this review, we discuss the contribution of major classic, spontaneous, and humanized EAE models to our understanding of MS pathophysiology and to insights leading to devising current and future therapies for this disease.
Keywords: Antigen-based immune-specific therapy; Experimental autoimmune encephlalomyelitis (EAE); HLA-II transgenic mice; Humanized EAE models; Multiple sclerosis (MS); Spontaneous EAE models.
Copyright © 2014 Elsevier Ltd. All rights reserved.
Similar articles
-
Comparing the CNS morphology and immunobiology of different EAE models in C57BL/6 mice - a step towards understanding the complexity of multiple sclerosis.Ann Anat. 2008;190(1):1-15. doi: 10.1016/j.aanat.2007.11.001. Ann Anat. 2008. PMID: 18342137
-
Modelling MS: Chronic-Relapsing EAE in the NOD/Lt Mouse Strain.Curr Top Behav Neurosci. 2015;26:143-77. doi: 10.1007/7854_2015_378. Curr Top Behav Neurosci. 2015. PMID: 26126592 Review.
-
Gene Expression in Spontaneous Experimental Autoimmune Encephalomyelitis Is Linked to Human Multiple Sclerosis Risk Genes.Front Immunol. 2020 Sep 18;11:2165. doi: 10.3389/fimmu.2020.02165. eCollection 2020. Front Immunol. 2020. PMID: 33072080 Free PMC article.
-
Mannan-conjugated myelin peptides prime non-pathogenic Th1 and Th17 cells and ameliorate experimental autoimmune encephalomyelitis.Exp Neurol. 2015 May;267:254-67. doi: 10.1016/j.expneurol.2014.10.019. Epub 2014 Oct 30. Exp Neurol. 2015. PMID: 25447934
-
The role of myelin oligodendrocyte glycoprotein in autoimmune demyelination: a target for multiple sclerosis therapy?Expert Opin Ther Targets. 2012 May;16(5):451-62. doi: 10.1517/14728222.2012.677438. Epub 2012 Apr 12. Expert Opin Ther Targets. 2012. PMID: 22494461 Review.
Cited by
-
Opioid growth factor and low-dose naltrexone impair central nervous system infiltration by CD4 + T lymphocytes in established experimental autoimmune encephalomyelitis, a model of multiple sclerosis.Exp Biol Med (Maywood). 2016 Jan;241(1):71-8. doi: 10.1177/1535370215596384. Epub 2015 Jul 22. Exp Biol Med (Maywood). 2016. PMID: 26202376 Free PMC article.
-
Altered Regulatory B Cell Subsets in Children with Type 1 Diabetes Mellitus.J Immunol Res. 2020 Jul 21;2020:8935694. doi: 10.1155/2020/8935694. eCollection 2020. J Immunol Res. 2020. PMID: 32775471 Free PMC article.
-
Antigen-Specific Treatment Modalities in MS: The Past, the Present, and the Future.Front Immunol. 2021 Feb 19;12:624685. doi: 10.3389/fimmu.2021.624685. eCollection 2021. Front Immunol. 2021. PMID: 33679769 Free PMC article. Review.
-
The Anti-Aging Protein Klotho Enhances Remyelination Following Cuprizone-Induced Demyelination.J Mol Neurosci. 2015 Oct;57(2):185-96. doi: 10.1007/s12031-015-0598-2. Epub 2015 Jun 12. J Mol Neurosci. 2015. PMID: 26067431
-
DCIR2+ cDC2 DCs and Zbtb32 Restore CD4+ T-Cell Tolerance and Inhibit Diabetes.Diabetes. 2015 Oct;64(10):3521-31. doi: 10.2337/db14-1880. Epub 2015 Jun 12. Diabetes. 2015. PMID: 26070317 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
